Discover
OVID
Ovid Therapeutics Inc.
2.69
2 x 1.93
2 x 3.40
bid
ask
-
0.01
0.37%
2 @ 04:00 PM
2.69 +0.00 (0.00%)
| Ytd | 65.03% | |
| 1y | 120.49% |
2.63
day range
2.73
1.18
52 week range
3.10
| Open | 2.68 | Prev Close | 2.70 | Low | 2.63 | High | 2.73 | Mkt Cap | 525.35M |
| Vol | 5.90M | Avg Vol | 2.01M | EPS | -0.21 | P/E | N/A | Forward P/E | -2.44 |
| Beta | 0.41 | Short Ratio | 3.05 | Inst. Own | 56.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 2.62 | 200-d Avg | 2.25 | 1yr Est | 3.26 |
| Income Statement | |||
| Total Revenue | 733.00K | ||
| Revenues (USD) | 733.00K | ||
| Gross Profit | 733.00K | ||
| Operating Expenses | 16.43M | ||
| Research and Development Expense | 9.96M | ||
| Selling, General and Administrative Expense | 6.47M | ||
| Operating Income | -15.70M | ||
| Net Income | -15.01M | ||
| Net Income Common Stock | -15.01M | ||
| Net Income Common Stock (USD) | -15.01M | ||
| Consolidated Income | -15.01M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -15.01M | ||
| Earning Before Interest & Taxes (USD) | -15.01M | ||
| Weighted Average Shares | 197.45M | ||
| Weighted Average Shares Diluted | 197.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.26M | ||
| Cash and Equivalents (USD) | 13.26M | ||
| Investments | 201.14M | ||
| Investments Current | 105.89M | ||
| Investments Non-Current | 95.24M | ||
| Current Assets | 123.62M | ||
| Property, Plant & Equipment Net | 11.18M | ||
| Total Assets | 231.97M | ||
| Debt Current | 1.48M | ||
| Total Debt | 13.59M | ||
| Current Liabilities | 9.98M | ||
| Debt Non-Current | 12.10M | ||
| Total Liabilities | 22.08M | ||
| Accumulated Retained Earnings (Deficit) | -353.71M | ||
| Accumulated Other Comprehensive Income | -750.00K | ||
| Shareholders Equity | 209.89M | ||
| Shareholders Equity (USD) | 209.89M | ||
| Assets Non-Current | 108.36M | ||
| Total Debt (USD) | 13.59M | ||
| Liabilities Non-Current | 12.10M | ||
| Trade and Non-Trade Payables | 4.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 334.00K | ||
| Net Cash Flow from Financing | 21.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -82.74M | ||
| Issuance (Purchase) of Equity Shares | 21.60M | ||
| Net Cash Flow from Investing | -86.74M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -86.74M | ||
| Net Cash Flow from Operations | -17.59M | ||
| Effect of Exchange Rate Changes on Cash | -4.00K | ||
| Share Based Compensation | 1.43M | ||